215 related articles for article (PubMed ID: 16917845)
21. Statistical optimization of indomethacin pellets coated with pH-dependent methacrylic polymers for possible colonic drug delivery.
Akhgari A; Afrasiabi Garekani H; Sadeghi F; Azimaie M
Int J Pharm; 2005 Nov; 305(1-2):22-30. PubMed ID: 16236475
[TBL] [Abstract][Full Text] [Related]
22. Colon-targeted delivery of solubilized bisacodyl by doubly enteric-coated multiple-unit tablet.
Park HJ; Jung HJ; Ho MJ; Lee DR; Cho HR; Choi YS; Jun J; Son M; Kang MJ
Eur J Pharm Sci; 2017 May; 102():172-179. PubMed ID: 28279763
[TBL] [Abstract][Full Text] [Related]
23. Development of a novel tablet-in-capsule formulation of mesalamine for inflammatory bowel disease.
Patel MM; Amin AF
Pharm Dev Technol; 2013; 18(2):390-400. PubMed ID: 22304735
[TBL] [Abstract][Full Text] [Related]
24. Evolution of a physiological pH 6.8 bicarbonate buffer system: application to the dissolution testing of enteric coated products.
Liu F; Merchant HA; Kulkarni RP; Alkademi M; Basit AW
Eur J Pharm Biopharm; 2011 May; 78(1):151-7. PubMed ID: 21255647
[TBL] [Abstract][Full Text] [Related]
25. Studies of chitosan/organic acid/Eudragit RS/RL-coated system for colonic delivery.
Kaur K; Kim K
Int J Pharm; 2009 Jan; 366(1-2):140-8. PubMed ID: 18835342
[TBL] [Abstract][Full Text] [Related]
26. Eudragit S100 coated microsponges for Colon targeting of prednisolone.
Kumari A; Jain A; Hurkat P; Tiwari A; Jain SK
Drug Dev Ind Pharm; 2018 Jun; 44(6):902-913. PubMed ID: 29260916
[TBL] [Abstract][Full Text] [Related]
27. Comparison of simple Eudragit microparticles loaded with prednisolone and Eudragit-coated chitosan-succinyl-prednisolone conjugate microparticles: Part I. Particle characteristics and in vitro evaluation as a colonic delivery system.
Onishi H; Kikuchi H; Machida Y
Drug Dev Ind Pharm; 2012 Jul; 38(7):800-7. PubMed ID: 22077373
[TBL] [Abstract][Full Text] [Related]
28. Fabrication and in vivo evaluation of highly pH-responsive acrylic microparticles for targeted gastrointestinal delivery.
Kendall RA; Alhnan MA; Nilkumhang S; Murdan S; Basit AW
Eur J Pharm Sci; 2009 Jun; 37(3-4):284-90. PubMed ID: 19491017
[TBL] [Abstract][Full Text] [Related]
29. Pulsatile drug delivery to ileo-colonic segments by structured incorporation of disintegrants in pH-responsive polymer coatings.
Schellekens RC; Stellaard F; Mitrovic D; Stuurman FE; Kosterink JG; Frijlink HW
J Control Release; 2008 Dec; 132(2):91-8. PubMed ID: 18775755
[TBL] [Abstract][Full Text] [Related]
30. Combination of time-dependent and pH-dependent polymethacrylates as a single coating formulation for colonic delivery of indomethacin pellets.
Akhgari A; Sadeghi F; Garekani HA
Int J Pharm; 2006 Aug; 320(1-2):137-42. PubMed ID: 16782290
[TBL] [Abstract][Full Text] [Related]
31. An in vivo comparison of intestinal pH and bacteria as physiological trigger mechanisms for colonic targeting in man.
McConnell EL; Short MD; Basit AW
J Control Release; 2008 Sep; 130(2):154-60. PubMed ID: 18639950
[TBL] [Abstract][Full Text] [Related]
32. Design, development and in vitro-in vivo study of a colon-specific fast disintegrating tablet.
Kshirsagar SJ; Bhalekar MR; Umap RR
Pharm Dev Technol; 2011 Oct; 16(5):449-56. PubMed ID: 20486875
[TBL] [Abstract][Full Text] [Related]
33. A novel concept in enteric coating: a double-coating system providing rapid drug release in the proximal small intestine.
Liu F; Lizio R; Meier C; Petereit HU; Blakey P; Basit AW
J Control Release; 2009 Jan; 133(2):119-24. PubMed ID: 18930772
[TBL] [Abstract][Full Text] [Related]
34. Design of a colonic delivery system based on cationic polymethacrylate (Eudragit E100)-mesalamine complexes.
Quinteros DA; Manzo RH; Allemandi DA
Drug Deliv; 2010 May; 17(4):208-13. PubMed ID: 20230248
[TBL] [Abstract][Full Text] [Related]
35. Relationship between drug dissolution and leaching of plasticizer for pellets coated with an aqueous Eudragit S100:L100 dispersion.
Bando H; McGinity JW
Int J Pharm; 2006 Oct; 323(1-2):11-7. PubMed ID: 16815652
[TBL] [Abstract][Full Text] [Related]
36. In vitro drug release and in vivo human X-ray studies of ileo-cecal targeting budesonide fast disintegrating tablet.
Kshirsagar SJ; Bhalekar MR; Pawar RP
Drug Dev Ind Pharm; 2009 Jul; 35(7):788-95. PubMed ID: 19337870
[TBL] [Abstract][Full Text] [Related]
37. Development of pH- and time-dependent oral microparticles to optimize budesonide delivery to ileum and colon.
Krishnamachari Y; Madan P; Lin S
Int J Pharm; 2007 Jun; 338(1-2):238-47. PubMed ID: 17368982
[TBL] [Abstract][Full Text] [Related]
38. In vivo evaluation of time and site of disintegration of polysaccharide tablet prepared for colon-specific drug delivery.
Sinha VR; Mittal BR; Kumria R
Int J Pharm; 2005 Jan; 289(1-2):79-85. PubMed ID: 15652201
[TBL] [Abstract][Full Text] [Related]
39. Novel preparation of enteric-coated chitosan-prednisolone conjugate microspheres and in vitro evaluation of their potential as a colonic delivery system.
Oosegi T; Onishi H; Machida Y
Eur J Pharm Biopharm; 2008 Feb; 68(2):260-6. PubMed ID: 17703928
[TBL] [Abstract][Full Text] [Related]
40. Eudragit FS 30 D: a new pH-sensitive polymer covering for mesalamine.
Potestà P
Eur Rev Med Pharmacol Sci; 2001; 5(1):30. PubMed ID: 11860220
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]